Rethinking
Drug Discovery

ABOUT US

Elix, Inc. is an AI drug discovery company with the mission of "Rethinking Drug Discovery".

In addition to talented AI researchers and AI engineers, many of the team members have Ph.D. degrees and come from different specialities such as chemistry, biology and physics. This diverse lineup gives us the capability to always be on the cutting-edge of AI research and development.

about

OUR
BUSINESS

Our clients are mainly from pharmaceutical companies and academia.

AI Drug Discovery

We conduct joint research with our partners through Elix's AI drug discovery platform Elix DiscoveryTM.
This platform brings cutting-edge technologies together to rapidly improve a range of tasks,mainly from hit-to-lead optimization.

Major Functions

  • Activity prediction / Property prediction,
  • ADMET prediction,
  • Molecular design,
  • Retrosynthesis analysis, etc.

Here are some of our major AI drug discovery partners

  • astellas
  • kaken
  • kyoto univ
  • riken
  • shionogi

Our Partners

We are working together with companies and research institutes in a wide range of industries towards problem solving and value creation.

  • Corporate Partners

    • asahi kasei
    • Astellas Pharma Inc.
    • Bridgestone Corporation
    • CAC Corporation
    • mitsubishi chemical holdings corporation
    • NIPPON SHOKUBAI CO., LTD.
    • Showa Denko K.K.
    • Honda R&D Co.,Ltd
    • kaken
    • KONICA MINOLTA, INC.
    • shionogi
    • Toppan
  • Research Institutes and Universities

    • Institute of Marerials Research and Engine
    • kyoto univ.
    • riken
    • chiba univ.
  • Selected Programs

    • block buster tokyo
    • nvidea

CAREERS

We are actively hiring research engineers for our business expansion!
You are most welcomed if you have experiences in machine learning or if you have Ph.D. in computer science, chemistry, biology, or equivalent practical skills and strong interests in AI drug discovery!
In addition, due to the increasing importance of specialized knowledge and experience in drug discovery, we would love to have people from the pharmaceutical industries!